Tourmaline Bio surges after Novartis $1.4 billion acquisition; analysts see strong fit
诺华(US:NVS) Invezz·2025-09-09 20:58Shares of Tourmaline Bio surged in premarket trading on Tuesday after the US-based biotechnology company agreed to be acquired by Swiss pharmaceutical major Novartis for approximately $1.4 billion. To... ...